Psychedelics, epilepsy, and seizures: a review

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Psychedelic compounds have historical and modern clinical applications.
• Current clinical trials exclude individuals with seizure histories, limiting therapeutic options.
• There is a lack of evidence that psychedelics induce or worsen seizures.

Purpose of the Study:

• To review the safety of psychedelic use in individuals with seizure disorders.
• To explore the potential for psychedelic-assisted therapy in this population.
• To identify future research directions.

Main Methods:

• Literature review of existing clinical trials and preclinical models.
• Analysis of case studies involving psychedelic use and seizure activity.
• Examination of trends in seizure outcomes following psychedelic administration.

Main Results:

• No clinical or preclinical evidence demonstrates psychedelics induce seizures.
• Case studies show varied outcomes, including seizure remission.
• The overall trend suggests safety in controlled, supervised settings.

Conclusions:

• Psychedelic-assisted therapy may be a viable option for patients with seizure disorders.
• Exclusion criteria in current trials may be unnecessarily restrictive.
• Further research is warranted to confirm safety and efficacy in this population.